Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22984346 | 0.81 | CYP2D6 (0.35) | CYP2D6 | |
| SCHEMBL20962518 | 0.80 | CYP2D6 (0.33) | CYP2D6 | |
| SCHEMBL19135637 | 0.79 | — | — | |
| SCHEMBL22845685 | 0.79 | — | — | |
| SCHEMBL24638971 | 0.77 | CYP2D6 (0.38) | CYP2D6 | |
| SCHEMBL18656563 | 0.77 | GAA (0.30) | — | |
| SCHEMBL22984343 | 0.76 | CYP2D6 (0.37) | CYP2D6 | |
| SCHEMBL14272690 | 0.73 | — | — | |
| SCHEMBL3308565 | 0.73 | PABPC1 (0.42) | — | |
| SCHEMBL10265045 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2023-11-21 | — | — | US | disclosed |
| US-9708339-B2 | 1,3-benzothiazinone, sulfoxide, and sulfone compounds with electrophilic substituent | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2017-07-18 | — | — | US | disclosed |
| US-9708339-B2 | 1,3-benzothiazinone, sulfoxide, and sulfone compounds with electrophilic substituent | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2017-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | BET1, BRD4, BRD3 | CYP2D6 1138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.